Endothelin (ET) is a vasoactive peptide that enhances angiogenesis through vascular-endothelial growth factor (VEGF) stimulation; hence, its receptors (ETAR and ETBR) can be used as molecular targets for imaging thyroid tumors [51]. The gene discussed is VEGFA; the disease is thyroid tumor.